InceptionR’s NovoCure NVCR Stock Holding History

InceptionR’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,077	Closed	-$208K	–	822
2025 Q4	$208K	Sell	16,077 -1,315	-8%	-$16.9K	0.06%	538
2025 Q3	$225K	Buy	17,392 +4,909	+39%	+$65.6K	0.05%	572
2025 Q2	$222K	Buy	+12,483	New	+$218K	0.05%	543

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

InceptionR's NVCR Position: Q1 2026 in Review

InceptionR sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 16,077 shares — an estimated $208K sold.

InceptionR first reported a position in NVCR in Q2 2025 and held it in 3 quarters. The position peaked at $225K in Q3 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

InceptionR reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
InceptionR sold 16,077 NovoCure shares in Q1 2026, an estimated $208K.
InceptionR first reported a position in NovoCure in Q2 2025 and held it in 3 quarters.
InceptionR's NovoCure position peaked at $225K in Q3 2025.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.